Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-03-17 @ 3:20 AM
Study NCT ID:
NCT05576532
Status:
UNKNOWN
Last Update Posted:
2023-06-28
First Post:
2022-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia
Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization: